Nabothian Cyst Protects or Facilitates Against Cervical Cancer

NCT04488991 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1005

Last updated 2020-07-28

No results posted yet for this study

Summary

Aim of the study to asses the realition between HPV infection, Nabothian Cyst and Cervical Intraepithelial lesions or Cervical Cancer

Conditions

Interventions

OTHER

Cervical Cancer Rate

In the end of the Research, we will compare cervical cancer rates between groups

Sponsors & Collaborators

  • Haseki Training and Research Hospital

    lead OTHER

Principal Investigators

  • Cihan Comba, MD · Sultangazi Haseki Training and Research Hospital

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-23
Primary Completion
2021-03-01
Completion
2021-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04488991 on ClinicalTrials.gov